Short Seller’s Bombshell Report Rattles Grifols: Stock Chart Points To Potential Further Decline
Grifols, the Spanish multinational pharmaceutical titan involved into blood-related medicines, saw its shares fall by 24% on Tuesday.
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
All news is property of their respective owners.
